Pancreatic Cancer Research

ResearcherWashington University in St. LouisActive in the last 2 years

Julie Kristina Schwarz

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-2407-7531; OpenAlex author ID A5088769540; NIH RePORTER profile ID 10780712. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
1
Labs led
0
Collaborators
13
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 grant

Papers 3

  1. Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer. Co-author DOI 10.1038/s41588-022-01157-1↗
  2. Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer. Co-author DOI 10.1016/j.ccell.2020.02.008↗
  3. Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies. Co-author DOI 10.1126/scitranslmed.aau9240↗

Grants 1

  1. Targeting Focal Adhesion Kinase to Improve RT-inducted Tumor Immunity R01CA248917↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. David G DeNardo · 2 shared papers, 1 shared grant, 2019–2024 · strength 0.89
  2. Hyun Kim · 1 shared grant, 2024 · strength 0.72
  3. Graham D. Hogg · 2 shared papers, 2019–2020 · strength 0.17
  4. Samarth Hegde · 2 shared papers, 2019–2020 · strength 0.17
  5. William G. Hawkins · 2 shared papers, 2019–2020 · strength 0.17
  6. Chong Zuo · 2 shared papers, 2019–2020 · strength 0.17
  7. Ryan C Fields · 2 shared papers, 2019–2020 · strength 0.17
  8. Brett H. Herzog · 1 shared paper, 2020 · strength 0.09
  9. Varintra E. Lander · 1 shared paper, 2020 · strength 0.09
  10. John M. Baer · 1 shared paper, 2020 · strength 0.09
  11. Carl DeSelm · 1 shared paper, 2020 · strength 0.09
  12. Roheena Z. Panni · 1 shared paper, 2019 · strength 0.08
  13. Xiaobo Li · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.